Cargando…

Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019

BACKGROUND: Many patients who have recovered from their coronavirus disease 2019 (COVID-19) episode continue to remain symptomatic and seek medical opinion. The clinical characteristics and echocardiography findings of such subjects have not been adequately studied. METHODS: The study included 472 s...

Descripción completa

Detalles Bibliográficos
Autores principales: De, Aniruddha, Bansal, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816519/
https://www.ncbi.nlm.nih.gov/pubmed/36607468
http://dx.doi.org/10.1007/s10554-022-02787-6
_version_ 1784864551512047616
author De, Aniruddha
Bansal, Manish
author_facet De, Aniruddha
Bansal, Manish
author_sort De, Aniruddha
collection PubMed
description BACKGROUND: Many patients who have recovered from their coronavirus disease 2019 (COVID-19) episode continue to remain symptomatic and seek medical opinion. The clinical characteristics and echocardiography findings of such subjects have not been adequately studied. METHODS: The study included 472 subjects (age 54.0 ± 13.4 years, 57% men) with previous COVID-19 (median duration since COVID-19 12.0 weeks, interquartile range 9.0–26.0 weeks) and 100 controls (age 53.9 ± 13.6 years, 53% men). All subjects underwent detailed clinical assessment and echocardiography, including measurement of left ventricular (LV) ejection fraction (EF) and global longitudinal strain (GLS). RESULTS: Less than third (29.2%) of the post-COVID subjects had needed hospitalization for their initial infection. Exertional dyspnea or breathing difficulty at rest were the commonest reasons for post-COVID presentation. As compared to controls, the post-COVID subjects had impaired LV systolic (LVEF 63.2 ± 2.2 vs. 61.9 ± 4.6, P = 0.007; GLS − 19.9 ± 2.6% vs. -17.6 ± 3.4%, P < 0.001) and diastolic function. Majority of those with reduced LV GLS had preserved LVEF. The patients presenting before 12 weeks were more likely to be symptomatic, but LV GLS did not differ. The patients needing hospitalization had higher burden of co-morbidities and significantly reduced LV GLS as compared to those who had received domiciliary treatment. The patients in the lowest GLS tertile were older, had higher burden of co-morbidities, and had had more severe initial infection with greater need for hospitalization, oxygen therapy and steroids. The need for hospitalization was independently associated with lower GLS at the time of current presentation. CONCLUSION: This study shows that impairment of LV systolic and diastolic function is common among subjects recovering from previous COVID-19 episode. The patients with more severe initial infection have more marked impairment of LV function and this impairment persists even after several months of recovery from the initial infection. Routine measurement of GLS may be helpful since LV systolic dysfunction in these patients is mostly subclinical.
format Online
Article
Text
id pubmed-9816519
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-98165192023-01-06 Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019 De, Aniruddha Bansal, Manish Int J Cardiovasc Imaging Original Paper BACKGROUND: Many patients who have recovered from their coronavirus disease 2019 (COVID-19) episode continue to remain symptomatic and seek medical opinion. The clinical characteristics and echocardiography findings of such subjects have not been adequately studied. METHODS: The study included 472 subjects (age 54.0 ± 13.4 years, 57% men) with previous COVID-19 (median duration since COVID-19 12.0 weeks, interquartile range 9.0–26.0 weeks) and 100 controls (age 53.9 ± 13.6 years, 53% men). All subjects underwent detailed clinical assessment and echocardiography, including measurement of left ventricular (LV) ejection fraction (EF) and global longitudinal strain (GLS). RESULTS: Less than third (29.2%) of the post-COVID subjects had needed hospitalization for their initial infection. Exertional dyspnea or breathing difficulty at rest were the commonest reasons for post-COVID presentation. As compared to controls, the post-COVID subjects had impaired LV systolic (LVEF 63.2 ± 2.2 vs. 61.9 ± 4.6, P = 0.007; GLS − 19.9 ± 2.6% vs. -17.6 ± 3.4%, P < 0.001) and diastolic function. Majority of those with reduced LV GLS had preserved LVEF. The patients presenting before 12 weeks were more likely to be symptomatic, but LV GLS did not differ. The patients needing hospitalization had higher burden of co-morbidities and significantly reduced LV GLS as compared to those who had received domiciliary treatment. The patients in the lowest GLS tertile were older, had higher burden of co-morbidities, and had had more severe initial infection with greater need for hospitalization, oxygen therapy and steroids. The need for hospitalization was independently associated with lower GLS at the time of current presentation. CONCLUSION: This study shows that impairment of LV systolic and diastolic function is common among subjects recovering from previous COVID-19 episode. The patients with more severe initial infection have more marked impairment of LV function and this impairment persists even after several months of recovery from the initial infection. Routine measurement of GLS may be helpful since LV systolic dysfunction in these patients is mostly subclinical. Springer Netherlands 2023-01-06 2023 /pmc/articles/PMC9816519/ /pubmed/36607468 http://dx.doi.org/10.1007/s10554-022-02787-6 Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
De, Aniruddha
Bansal, Manish
Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019
title Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019
title_full Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019
title_fullStr Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019
title_full_unstemmed Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019
title_short Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019
title_sort clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816519/
https://www.ncbi.nlm.nih.gov/pubmed/36607468
http://dx.doi.org/10.1007/s10554-022-02787-6
work_keys_str_mv AT deaniruddha clinicalprofileandtheextentofresidualmyocardialdysfunctionamongpatientswithpreviouscoronavirusdisease2019
AT bansalmanish clinicalprofileandtheextentofresidualmyocardialdysfunctionamongpatientswithpreviouscoronavirusdisease2019